Irvine, CA – According to filings with the U.S. Securities and Exchange Commission, Biolase is raising $6,912,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Todd Norbe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biolase

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE’s laser systems are designed to provide clinically superior, patient friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 36,200 laser systems to date in over 90 countries around the world.

To learn more about Biolase, visit http://www.biolase.com/

Contact:
Todd Norbe, President and Chief Executive Officer
949-361-1200

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved